Our specialized units cover diverse therapeutic areas such as endocrinology, metabolic disorders, cardiology, gastroenterology, women’s health, dermatology, hematology, and nephrology.
Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment.
